Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closed to Accrual

BI.1 -- A Phase III Study of Gemcitabine Plus Capecitabine (Gemcap) versus Gemcitabine Alone in Advanced Biliary Cancer -- was closed to accrual 14 July 2009.

http://www.ctg.queensu.ca/trials/gastro-intestinal/bi1/bi1.html